1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Bronchitis - Pipeline Review, H1 2015

Chronic Bronchitis - Pipeline Review, H1 2015

  • January 2015
  • -
  • Global Markets Direct
  • -
  • 49 pages

Chronic Bronchitis - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Chronic Bronchitis - Pipeline Review, H1 2015’, provides an overview of the Chronic Bronchitis’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Chronic Bronchitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Bronchitis and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Chronic Bronchitis
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Chronic Bronchitis and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Chronic Bronchitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Chronic Bronchitis pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Chronic Bronchitis
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Chronic Bronchitis pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table Of Contents

Chronic Bronchitis - Pipeline Review, H1 2015
Table of Contents
Introduction 5
Global Markets Direct Report Coverage 5
Chronic Bronchitis Overview 6
Therapeutics Development 7
Pipeline Products for Chronic Bronchitis - Overview 7
Pipeline Products for Chronic Bronchitis - Comparative Analysis 8
Chronic Bronchitis - Therapeutics under Development by Companies 9
Chronic Bronchitis - Pipeline Products Glance 10
Late Stage Products 10
Clinical Stage Products 11
Early Stage Products 12
Chronic Bronchitis - Products under Development by Companies 13
Chronic Bronchitis - Companies Involved in Therapeutics Development 14
Boehringer Ingelheim GmbH 14
Invion Limited 15
Nippon Shinyaku Co., Ltd. 16
Pharmaxis Limited 17
Chronic Bronchitis - Therapeutics Assessment 18
Assessment by Monotherapy Products 18
Assessment by Combination Products 19
Assessment by Target 20
Assessment by Mechanism of Action 22
Assessment by Route of Administration 24
Assessment by Molecule Type 26
Drug Profiles 27
(olodaterol + tiotropium bromide) - Drug Profile 27
Product Description 27
Mechanism of Action 27
RandD Progress 27
mannitol - Drug Profile 29
Product Description 29
Mechanism of Action 29
RandD Progress 29
nadolol - Drug Profile 32
Product Description 32
Mechanism of Action 32
RandD Progress 32
prulifloxacin - Drug Profile 34
Product Description 34
Mechanism of Action 34
RandD Progress 34
TRN-101 - Drug Profile 36
Product Description 36
Mechanism of Action 36
RandD Progress 36
Chronic Bronchitis - Recent Pipeline Updates 37
Chronic Bronchitis - Dormant Projects 45
Chronic Bronchitis - Discontinued Products 46
Chronic Bronchitis - Product Development Milestones 47
Featured News and Press Releases 47
Jul 22, 2013: INVION ANNOUNCES COMMENCEMENT OF PHASE II CHRONIC BRONCHITIS CLINICAL TRIAL 47
Appendix 48
Methodology 48
Coverage 48
Secondary Research 48
Primary Research 48
Expert Panel Validation 48
Contact Us 48
Disclaimer 49

List of Tables

Number of Products under Development for Chronic Bronchitis, H1 2015 7
Number of Products under Development for Chronic Bronchitis - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Late Stage Development, H1 2015 10
Comparative Analysis by Clinical Stage Development, H1 2015 11
Comparative Analysis by Early Stage Development, H1 2015 12
Products under Development by Companies, H1 2015 13
Chronic Bronchitis - Pipeline by Boehringer Ingelheim GmbH, H1 2015 14
Chronic Bronchitis - Pipeline by Invion Limited, H1 2015 15
Chronic Bronchitis - Pipeline by Nippon Shinyaku Co., Ltd., H1 2015 16
Chronic Bronchitis - Pipeline by Pharmaxis Limited, H1 2015 17
Assessment by Monotherapy Products, H1 2015 18
Assessment by Combination Products, H1 2015 19
Number of Products by Stage and Target, H1 2015 21
Number of Products by Stage and Mechanism of Action, H1 2015 23
Number of Products by Stage and Route of Administration, H1 2015 25
Number of Products by Stage and Molecule Type, H1 2015 26
Chronic Bronchitis Therapeutics - Recent Pipeline Updates, H1 2015 37
Chronic Bronchitis - Dormant Projects, H1 2015 45
Chronic Bronchitis - Discontinued Products, H1 2015 46

List of Figures

Number of Products under Development for Chronic Bronchitis, H1 2015 7
Number of Products under Development for Chronic Bronchitis - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Late Stage Development, H1 2015 10
Comparative Analysis by Early Stage Products, H1 2015 12
Assessment by Monotherapy Products, H1 2015 18
Number of Products by Top 10 Targets, H1 2015 20
Number of Products by Stage and Top 10 Targets, H1 2015 20
Number of Products by Top 10 Mechanism of Actions, H1 2015 22
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 22
Number of Products by Top 10 Routes of Administration, H1 2015 24
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 25
Number of Products by Stage and Top 10 Molecule Types, H1 2015 26

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Bovine Respiratory Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Bovine Respiratory Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

Global Bovine Respiratory Disease Treatment Market: Overview Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired ...

Chronic Obstructive Pulmonary Disease (COPD) - Market Insights, Epidemiology and Market Forecast-2023

Chronic Obstructive Pulmonary Disease (COPD) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Chronic Obstructive Pulmonary Disease (COPD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview ...

Allergic Rhinitis - Market Insights, Epidemiology and Market Forecast-2023

Allergic Rhinitis - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Allergic Rhinitis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.